logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hengrui Pharma (01276.HK): Certain products included in the 2026 National Medical Insurance Catalog

date
15/11/2026
Zhitong Finance APP news, Hengrui Pharmaceuticals (01276.HK) announced that some of the company's products have been included in the 2026 National Medical Insurance Catalog.
Latest
7 m ago
Lvcheng Culture (08627.HK) Signs Business Cooperation Agreement with Hong Kong Niuyouguo
11 m ago
Shuangdeng Group (06960.HK) repurchased 55,000 shares on November 13 for approximately HK$252,600.
12 m ago
Hengrui Pharma (01276.HK): Certain products included in the 2026 National Medical Insurance Catalog
15 m ago
Huanchuang Technology (06802.HK) Appoints Li Yanan as Joint Company Secretary
17 m ago
Hansoh Pharmaceutical (03692): Aumolertinib Marketing Authorization Receives Positive Opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.